Literature DB >> 29161706

Endotoxin Effects on Cardiac and Renal Functions and Cardiorenal Syndromes.

Grazia Maria Virzì1, Anna Clementi, Alessandra Brocca, Claudio Ronco.   

Abstract

Gram-negative sepsis is a major cause of morbidity and mortality in critical ill patients. Recent findings in molecular biology and in signaling pathways have enhanced our understanding of its pathogenesis and opened up opportunities of innovative therapeutic approaches. Endotoxin plays a pivotal role in the pathogenesis of multi-organ dysfunction in the setting of gram-negative sepsis. Indeed, heart and kidney impairments seem to be induced by the release of circulating pro-inflammatory and pro-apoptotic mediators triggered by endotoxin interaction with immune cells. These molecules are responsible for cellular apoptosis, autophagy, cell cycle arrest, and microRNAs activation. Therefore, the early identification of sepsis-associated acute kidney injury and heart dysfunction may improve the patient clinical outcome. In this report, we will consider the role of endotoxin in the pathogenesis of sepsis, its effects on both cardiac and renal functions, and the interactions between these 2 systems in the setting of cardiorenal syndromes (CRS), particularly in CRS type 5. Finally, we will discuss the possible role of extracorporeal therapies in reducing endotoxin levels.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Cardiorenal syndrome; Endotoxin; Heart; Kidney; Lipopolysaccharide; Sepsis

Mesh:

Substances:

Year:  2017        PMID: 29161706     DOI: 10.1159/000480424

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  6 in total

1.  Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1.

Authors:  Grazia Maria Virzì; Andrea Breglia; Chiara Castellani; Ghada Ankawi; Chiara Bolin; Massimo de Cal; Vito Cianci; Annalisa Angelini; Giorgio Vescovo; Claudio Ronco
Journal:  J Nephrol       Date:  2019-04-20       Impact factor: 3.902

2.  Potentially Important Therapeutic Interactions between Antibiotics, and a Specially Engineered Emulsion Drug Vehicle Containing Krill-Oil-Based Phospholipids and Omega-3 Fatty Acids.

Authors:  David F Driscoll
Journal:  Antibiotics (Basel)       Date:  2018-03-10

3.  In vivo evaluation of the protective effects of arjunolic acid against lipopolysaccharide-induced septic myocardial injury.

Authors:  Hany Elsawy; Mohammed Almalki; Omar Elmenshawy; Ashraf Abdel-Moneim
Journal:  PeerJ       Date:  2022-02-16       Impact factor: 2.984

4.  Klotho downregulation contributes to myocardial damage of cardiorenal syndrome in sepsis.

Authors:  Fei Yan; Yue Feng; Jin Chen; Jing Yan
Journal:  Mol Med Rep       Date:  2020-05-22       Impact factor: 2.952

5.  Potential role of lncRNA HULC/miR‑128‑3p/RAC1 axis in the inflammatory response during LPS‑induced sepsis in HMEC‑1 cells.

Authors:  Weize Yang; Xiaomin Luo; Yu Liu; Jun Xiong; Hongxia Xia; Yafeng Liu
Journal:  Mol Med Rep       Date:  2020-10-14       Impact factor: 2.952

Review 6.  Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.

Authors:  Giacomo Ruzzenenti; Alessandro Maloberti; Valentina Giani; Marco Biolcati; Filippo Leidi; Massimiliano Monticelli; Enzo Grasso; Iside Cartella; Matteo Palazzini; Laura Garatti; Nicola Ughi; Claudio Rossetti; Oscar Massimiliano Epis; Cristina Giannattasio
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.